Medical News Today -- St. Jude Medical, Inc. (NYSE: STJ) announced the first use of the PressureWire™ Aeris technology, an interventional tool which measures Fractional Flow Reserve (FFR) to evaluate the severity of blood flow blockages in the arteries. This first-to-market technology helps interventional cardiologists better determine the ideal treatment option for their patients during coronary interventions, such as stent procedures. The first procedures in the U.S. were performed by Dr. Mark Zolnick at CHRISTUS St. Vincent Regional Medical Center in Santa Fe, New Mexico.
